Cargando…

Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model

Angelman syndrome (AS) is a severe neurodevelopmental disorder for which only symptomatic treatment with limited benefits is available. AS is caused by mutations affecting the maternally inherited ubiquitin protein ligase E3A (UBE3A) gene. Previous studies showed that the silenced paternal Ube3a gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milazzo, Claudia, Mientjes, Edwin J., Wallaard, Ilse, Rasmussen, Søren Vestergaard, Erichsen, Kamille Dumong, Kakunuri, Tejaswini, van der Sman, A.S. Elise, Kremer, Thomas, Miller, Meghan T., Hoener, Marius C., Elgersma, Ype
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410092/ https://www.ncbi.nlm.nih.gov/pubmed/34369389 http://dx.doi.org/10.1172/jci.insight.145991

Ejemplares similares

Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome
por: Sonzogni, Monica, et al.
Publicado: (2020)

A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel Ube3a mutants
por: Sonzogni, Monica, et al.
Publicado: (2018)

UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome
por: Elgersma, Ype, et al.
Publicado: (2021)

Secreted retrovirus-like GAG-domain-containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology
por: Pandya, Nikhil J., et al.
Publicado: (2021)

Multidimensional analysis of behavior predicts genotype with high accuracy in a mouse model of Angelman syndrome
por: Tanas, Joseph K., et al.
Publicado: (2022)

UBE3A expression during early postnatal brain development is required for proper dorsomedial striatal maturation
por: Rotaru, Diana C., et al.
Publicado: (2023)

Longitudinal EEG model detects antisense oligonucleotide treatment effect and increased UBE3A in Angelman syndrome
por: Spencer, Elizabeth R., et al.
Publicado: (2022)

Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes
por: Sonzogni, Monica, et al.
Publicado: (2019)

The role of ubiquitin ligase E3A in polarized contact guidance and rescue strategies in UBE3A-deficient hippocampal neurons
por: Tonazzini, Ilaria, et al.
Publicado: (2019)

Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations
por: Bossuyt, Stijn N V, et al.
Publicado: (2021)

A cross-species spatiotemporal proteomic analysis identifies UBE3A-dependent signaling pathways and targets
por: Pandya, Nikhil J., et al.
Publicado: (2022)

Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome
por: Lee, Dongwon, et al.
Publicado: (2023)

Dual-isoform hUBE3A gene transfer improves behavioral and seizure outcomes in Angelman syndrome model mice
por: Judson, Matthew C., et al.
Publicado: (2021)

Enhanced Transmission at the Calyx of Held Synapse in a Mouse Model for Angelman Syndrome
por: Wang, Tiantian, et al.
Publicado: (2018)

From first report to clinical trials: a bibliometric overview and visualization of the development of Angelman syndrome research
por: Zampeta, F. Isabella, et al.
Publicado: (2022)

Mono-ubiquitination of Rabphilin 3A by UBE3A serves a non-degradative function
por: Avagliano Trezza, Rossella, et al.
Publicado: (2021)

A novel UBE3A sequence variant identified in eight related individuals with neurodevelopmental delay, results in a phenotype which does not match the clinical criteria of Angelman syndrome
por: Geerts‐Haages, Amber, et al.
Publicado: (2020)

Calmodulin kinase II regulates amphetamine-induced reverse transport in the dopamine transporter: implications for the importance of the dopamine transporter in Angelman syndrome
por: Steinkellner, Thomas, et al.
Publicado: (2010)

From UBE3A to Angelman syndrome: a substrate perspective
por: Sell, Gabrielle L., et al.
Publicado: (2015)

Identifying the temporal electrophysiological and molecular changes that contribute to TSC-associated epileptogenesis
por: Koene, Linda M.C., et al.
Publicado: (2021)

Adult Camk2a gene reinstatement restores the learning and plasticity deficits of Camk2a knockout mice
por: Rigter, Pomme M.F., et al.
Publicado: (2022)

The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome
por: Viho, Eva M. G., et al.
Publicado: (2022)

Clinical aspects of a large group of adults with Angelman syndrome
por: den Besten, Inge, et al.
Publicado: (2020)

Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice
por: Sell, Gabrielle L., et al.
Publicado: (2021)

Hyperphagia, Growth, and Puberty in Children with Angelman Syndrome
por: Bindels-de Heus, Karen G. C. B., et al.
Publicado: (2023)

Early Origin and Evolution of the Angelman Syndrome Ubiquitin Ligase Gene Ube3a
por: Sato, Masaaki
Publicado: (2017)

Strain-dependence of the Angelman Syndrome phenotypes in Ube3a maternal deficiency mice
por: Born, Heather A., et al.
Publicado: (2017)

Truncation of Ube3a-ATS Unsilences Paternal Ube3a and Ameliorates Behavioral Defects in the Angelman Syndrome Mouse Model
por: Meng, Linyan, et al.
Publicado: (2013)

Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing
por: Stanurova, Jana, et al.
Publicado: (2016)

Persistent neuronal Ube3a expression in the suprachiasmatic nucleus of Angelman syndrome model mice
por: Jones, Kelly A., et al.
Publicado: (2016)

Corrigendum: Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing
por: Stanurova, Jana, et al.
Publicado: (2018)

Inhibition of EGF Uptake by Nephrotoxic Antisense Drugs In Vitro and Implications for Preclinical Safety Profiling
por: Moisan, Annie, et al.
Publicado: (2017)

Antisense oligonucleotides in neurological disorders
por: Wurster, Claudia D., et al.
Publicado: (2018)

Molecular Mechanisms of Antisense Oligonucleotides
por: Crooke, Stanley T.
Publicado: (2017)

Antisense oligonucleotides: A primer
por: Scoles, Daniel R., et al.
Publicado: (2019)

Antisense Oligonucleotides and RNA Interference
por: Kher, Gitanjali, et al.
Publicado: (2011)

Conserved UBE3A subcellular distribution between human and mice is facilitated by non-homologous isoforms
por: Zampeta, F Isabella, et al.
Publicado: (2020)

Angelman Syndrome Protein Ube3a Regulates Synaptic Growth and Endocytosis by Inhibiting BMP Signaling in Drosophila
por: Li, Wenhua, et al.
Publicado: (2016)

The role of whole exome sequencing in the UBE3A point mutation of Angelman Syndrome: A case report
por: Triono, Agung, et al.
Publicado: (2021)

Effects of antiepileptic drugs in a new TSC/mTOR‐dependent epilepsy mouse model
por: Koene, Linda M. C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vrgql5h1rt2qk882aupvv3rqqd